Biological Activity
Description of Danusertib: Danusertib is a small-molecule 3-aminopyrazole derivative with potential antineoplastic activity. Aurora kinase inhibitor PHA-739358 binds to and inhibits the Aurora kinases, which may result in cell growth arrest and apoptosis in tumor cells in which Aurora kinases are overexpressed. This agent may preferentially bind to and inhibit Aurora B kinase. Aurora kinases, a family of serine-threonine kinases, are important regulators of cellular proliferation and division. Check For active clinical trials or closed clinical trials using this agent. (NCI Thesaurus) . For the detailed information about the solubility of PHA-739358 danusertib in water, the solubility of PHA-739358 danusertib in DMSO, the solubility of PHA-739358 danusertib in PBS buffer, the animal experiment（test） of PHA-739358 danusertib,the in vivo,in vitro and clinical trial test of PHA-739358 danusertib,the cell experiment（test） of PHA-739358 danusertib,the IC50, EC50 and Affinity of PHA-739358 danusertib, please contact DC Chemicals.
In Vitro
No in vitro data are provided in the current product source. Contact us for further information.
In Vivo
No in vivo data are provided in the current product source. Contact us for further information.
References & source
Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.